SYNTHETIC DEMONSTRATION — no real student or patient. Not a medical device.

obgyn-repro

Hot Flashes at Night: How to Reduce Menopause Night Sweats

Hot flashes and night sweats — vasomotor symptoms of perimenopause and menopause — can be reduced through lifestyle adjustments (cool bedroom, avoiding triggers), non-hormonal medications (fezolinetant, SSRIs/SNRIs, gabapentin), or hormone therapy. Hormone therapy remains the most effective option for women under 60 or within 10 years of menopause with no contraindications.

Talk to a clinician

Gale can match you with a licensed clinician for a visit.

Find care →

Why do hot flashes and night sweats happen?

Vasomotor symptoms occur because falling estrogen levels affect the hypothalamus — the brain region that regulates body temperature. The temperature set point becomes narrower, meaning the body interprets small temperature rises as overheating and triggers an aggressive cooling response: blood vessels dilate, skin flushes, and sweating begins. At night, this can wake a person repeatedly and leave bedding soaked.

Vasomotor symptoms typically begin in perimenopause and often peak in the year or two after the last menstrual period, though they can persist for many years in some people. On average, hot flashes last around seven years, with significant individual variation 2.

What lifestyle changes can reduce hot flashes?

Several adjustments can meaningfully reduce frequency and intensity, particularly for people with mild to moderate symptoms:

Temperature management: - Keep the bedroom cool at night — a lower thermostat setting, a fan directed at the bed, or cooling mattress pads can make a meaningful difference - Use layered, breathable bedding that can be easily removed - Dress in moisture-wicking, lightweight fabrics - Keep a cold water bottle at the bedside

Identifying and avoiding triggers: Common hot flash triggers include alcohol, caffeine, spicy food, hot beverages, and warm environments. Keeping a brief log for a week or two to identify personal triggers can help.

Avoiding tobacco: Smoking is associated with more frequent and severe hot flashes. Quitting smoking has multiple health benefits including potential improvement in vasomotor symptoms.

Paced respiration: Slow, controlled breathing at the onset of a hot flash — breathing in for four counts, out for four counts — has been studied as a self-management technique. It may not shorten the episode but can reduce distress and perceived severity.

Does exercise help with hot flashes?

Regular physical activity is beneficial for general health during the menopause transition, but the evidence that it directly reduces hot flash frequency is mixed. Some studies suggest modest improvement; others show no difference in frequency. Exercise does meaningfully improve sleep quality, mood, cardiovascular health, and bone density — all of which matter during this transition — making it worth doing regardless of its direct effect on hot flashes.

Are there effective non-hormonal medications for hot flashes?

Several non-hormonal prescription options exist for people who cannot or prefer not to use hormone therapy:

Fezolinetant (Veozah). The first FDA-approved non-hormonal medication specifically designed to treat moderate to severe vasomotor symptoms. It targets neurokinin-3 receptors in the brain that trigger hot flashes — a different mechanism from hormone therapy. Phase 3 clinical trials demonstrated significant reductions in hot flash frequency and severity at 4 and 12 weeks, maintained through 52 weeks 3. The FDA added a boxed warning about rare serious liver injury in 2024; liver enzyme monitoring is recommended during use.

SSRIs and SNRIs. Certain antidepressants — paroxetine (the only one with FDA approval specifically for vasomotor symptoms), venlafaxine, and escitalopram — reduce hot flash frequency by roughly 50–60% in clinical trials. They are a reasonable option for people who cannot use hormone therapy.

Gabapentin. Originally an anticonvulsant, gabapentin reduces hot flash frequency and is sometimes preferred for people who also have sleep disruption from night sweats.

Clonidine. An older blood-pressure medication occasionally used, with more modest evidence than the above options.

What about hormone therapy for hot flashes?

Menopausal hormone therapy — estrogen with or without progestogen — remains the most effective treatment for vasomotor symptoms 1. The 2022 North American Menopause Society position statement concludes that for healthy women under 60 or within 10 years of menopause onset, benefits generally outweigh risks for symptom management 1. Transdermal forms (patches, gels) are often preferred over oral pills because they appear to carry lower risks of blood clots.

Local vaginal estrogen (cream, tablet, or ring applied directly to the vagina) treats genitourinary symptoms with minimal systemic absorption and carries a different risk profile — but does not address hot flashes.

What about herbal and supplement options?

Many supplements are marketed for hot flash relief — black cohosh, soy isoflavones, red clover, evening primrose oil, and others. Clinical trial evidence is generally inconsistent and of modest quality. Some people report subjective improvement; rigorous trials rarely show effects beyond placebo for most of these.

Black cohosh is the most studied. Some trials show modest reduction in hot flash frequency; others do not. Soy isoflavones (phytoestrogens) have a mild estrogen-like effect, with mixed results across trials. If you wish to try a supplement, discuss it with a clinician — some interact with medications, and 'natural' does not mean without risk. Gale can help you prepare questions about supplements for your clinician visit.

Common questions

How long do hot flashes last in menopause?

The average duration is approximately seven years, though there is wide individual variation — some people experience them for only a year or two, while others have vasomotor symptoms for more than a decade. Symptoms often begin in perimenopause, peak around the final menstrual period, and gradually diminish.

Is it safe to take hormone therapy just for night sweats if my hot flashes are mainly at night?

Yes. Vasomotor symptoms that primarily disrupt sleep are a valid reason to consider hormone therapy. Night sweat-related insomnia can significantly affect health, mood, and functioning. The risk-benefit framework is the same as for daytime hot flashes — discuss your individual situation with a clinician.

Can night sweats have causes other than menopause?

Yes. Night sweats can also result from thyroid disease, certain medications, infections, autoimmune conditions, or other causes. If you are pre-menopausal or if the pattern seems unusual, a workup to rule out other causes is appropriate before attributing sweating to menopause.

Do hot flashes affect heart health?

Some research suggests that frequent, severe vasomotor symptoms — particularly those that persist long after menopause — are associated with modestly elevated cardiovascular risk. This is another reason to take significant hot flashes seriously and to discuss management with a clinician rather than simply waiting them out.

Talk to a clinician

Gale can match you with a licensed clinician for a visit.

Find care →

When hot flashes warrant evaluation

  • Night sweats in a pre-menopausal person without an obvious hormonal explanation
  • Night sweats accompanied by unexplained weight loss, fever, or enlarged lymph nodes — these patterns can indicate conditions unrelated to menopause that require evaluation
  • Hot flashes severe enough to prevent adequate sleep for extended periods
  • Hot flashes beginning or worsening after starting a new medication

This article is general health education. The right treatment approach for hot flashes and night sweats depends on your health history, other conditions, and preferences. Discuss options with a gynecologist or clinician with menopause expertise before starting any medication, including non-hormonal prescriptions.

References

  1. 1.Faubion SS, Crandall CJ, Davis L, El Khoudary SR, Hodis HN, Lobo RA, Maki PM, Manson JE, Pinkerton JV, Santoro NF, Shifren JL, Shufelt CL, Thurston RC, Wolfman W (2022). The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. doi:10.1097/GME.0000000000002028Hormone therapy as the most effective treatment for vasomotor symptoms; risk-benefit framework for women under 60 or within 10 years of menopause; supports transdermal over oral for lower clot risk
  2. 2.American College of Obstetricians and Gynecologists (2022). The Menopause Years (Patient FAQ). ACOG Women's Health. linkAverage duration and characteristics of hot flashes during the menopause transition; overview of lifestyle and treatment approaches
  3. 3.Neal-Perry G, Cano A, Lederman S, Nappi RE, Santoro N, Wolfman W, English M, Franklin C, Valluri U, Ottery FD (2023). Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause: A Randomized Controlled Trial. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000005114FDA-approved non-hormonal neurokinin-3 receptor antagonist (fezolinetant) demonstrating significant reduction in hot flash frequency and severity in phase 3 SKYLIGHT trials; well-tolerated safety profile at 52 weeks

3 sources, numbered by first appearance. General health information, not medical advice — synthetic demonstration content.